Delivery Order SPE2DB25D3110-SPE2DB25FTCSW

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,456.00, is for the delivery of PRIORIX VIALS. The contract is a firm fixed-price delivery order with a completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.62 firm fixed-price contract is for the supply of PRIORIX VIALS, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $5,008.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of March 11, 2025. The award is not associated with a set-aside designation, indicating open competition. The contract covers the delivery of PRIORIX VIALS, a medical product, to support military...
This federal contract award, valued at $24,271.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for PRIORIX VIALS, a medical product, with a completion date of March 3, 2025. The contract is a firm-fixed-price agreement and was not set aside for any specific business designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $4,438.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a medical product, with a period of performance through May 29, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,715.40 firm-fixed-price delivery order is for the supply of PRIORIX VIALS, a medical product, with a period of performance through September 4, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,845.85 firm fixed-price delivery order contract is for the procurement of 4566803457 PRIORIX VIALS, with an ultimate completion date of December 30, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,140.20, is for the delivery of PRIORIX VIALS, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the procurement of a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,573.28 firm fixed-price delivery order is for PRIORIX VIALS, a medical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $26,140.00, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a pharmaceutical product, with a completion date of February 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB25D3110
    Indefinite Delivery Contract
  • SPE2DB25D3110-SPE2DB25FTCSW
    Delivery Order

This federal contract award, valued at $1,009.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific contract award is for PRIORIX VIALS, a medical product, with a performance period ending on March 11, 2025. The contract was awarded on a full and open competition basis, with no set-aside designation.

Generated 6/9/25, 9:44 AM